St. Jude Medical (St. Paul, Minnesota) reported the first patient enrollment in its ILUMIEN I clinical study. This observational study is designed to show the optimal way optical coherence tomography (OCT), an intravascular imaging technology, combined with the St. Jude PressureWire Aeris, a wireless interventional tool designed to measure fractional flow reserve (FFR), can guide stent implementation in patients with coronary artery disease.

The first patient has been implanted with the Boston Scientific next generation Ingevity pacing leads in a clinical trial designed to establish the safety, performance and effectiveness of the leads, the company reported.